Prognosis of patients with fulminant myocarditis managed by peripheral venoarterial extracorporeal membranous oxygenation support: A retrospective single-center study

Journal of Intensive Care

Volumn 3, Issue 1, 2015, Pages

  Nakamura, Tomohiro ^a   Ishida, Kohki ^a   Taniguchi, Yousuke ^a   Nakagawa, Tomu ^a   Seguchi, Masaru ^a   Wada, Hiroshi ^a   Sugawara, Yoshitaka ^a   Funayama, Hiroshi ^a   Mitsuhashi, Takeshi ^a   Momomura, Shin ichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Extracorporeal membranous oxygenation support; Fulminant myocarditis; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATINE KINASE; CREATINE KINASE MB; CREATININE; LACTATE DEHYDROGENASE; STEROID;

ADULT; AGE; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; EXTRACORPOREAL OXYGENATION; FEMALE; FULMINANT MYOCARDITIS; HUMAN; INTRAAORTIC BALLOON PUMP; LEG ISCHEMIA; MALE; MULTIPLE ORGAN FAILURE; MYOCARDITIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT DURATION;

EID: 84979195160     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/s40560-014-0069-9     Document Type: Article

References (13)

1. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathologic description of myocarditis. J Am Coll Cardiol. 1991, 18:1617-26. 10.1016/0735-1097(91)90493-S, 1960305.
2. Cooper LT. Myocarditis. N Engl J Med. 2009, 360:1526-38. 10.1056/NEJMra0800028, 19357408.
3. Chen JM, Spanier TB, Gonzalez JJ, Marelli D, Flannery MA, Tector KA, et al. Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance. J Heart Lung Transplant. 1999, 18:351-7. 10.1016/S1053-2498(98)00054-0, 10226900.
4. Acker MA. Mechanical circulatory support for patients with acute-fulminant myocarditis. Ann Thorac Surg. 2001, 71:S73-6. 10.1016/S0003-4975(00)02628-X, 11265870.
5. Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg. 2001, 122:440-8. 10.1067/mtc.2001.115243, 11547292.
6. Asaumi Y, Yasuda S, Morii I, Kakuchi H, Otsuka Y, Kawamura A, et al. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J. 2005, 26:2185-92. 10.1093/eurheartj/ehi411, 16014643.
7. Aoyama N, Izumi T, Hiramori K, Isobe M, Kawana M, Hiroe M, et al. National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J. 2002, 66:133-44. 10.1253/circj.66.133, 11999637.
8. Pages ON, Aubert S, Combes A, Luyt CE, Pavie A, Léger P, et al. Paracorporeal pulsatile biventricular assist device versus extracorporal membrane oxygenation-extracorporal life support in adult fulminant myocarditis. J Thorac Cardiovasc Surg. 2009, 137:194-7. 10.1016/j.jtcvs.2008.09.051, 19154925.
9. Sakamoto S, Taniguchi N, Nakajima S, Takahashi A. Extracorporeal life support for cardiogenic shock or cardiac arrest due to acute coronary syndrome. Ann Thorac Surg. 2012, 94:1-7. 10.1016/j.athoracsur.2012.01.032, 22429669.
10. Aoyama N, Imai H, Kurosawa T, Fukuda N, Moriguchi M, Nishinari M, et al. Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction. J Artif Organs. 2014, 17:33-41. 10.1007/s10047-013-0735-z, 24162152.
11. Peek GJ, Killer HM, Sosnowski MA, Firmin RK. Modular extracorporeal life support for multiorgan failure patients. Liver. 2002, 22(Suppl 2):69-71. 10.1034/j.1600-0676.2002.00014.x, 12220309.
12. Unosawa S, Hata M, Sezai A, Niino T, Yoshitake I, Shimura K, et al. Successful management of fulminant myocarditis with left ventricular assist device: report of a severe case. Ann Thorac Cardiovasc Surg. 2010, 16:48-51. 20190711.
13. Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, et al. Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device. Circ J. 2013, 77:96-104. 10.1253/circj.CJ-12-0686, 22972419.